Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-01-04 @ 8:39 AM
Study NCT ID:
NCT03148795
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2017-05-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-09
First Submit QC Date:
None
Study First Post Date:
2017-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-11
Results First Submit QC Date:
None
Results First Post Date:
2021-09-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-07
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL